PremiumBlurbsAnalysts Offer Insights on Healthcare Companies: Climb Bio (CLYM) and Longeveron (LGVN)1d agoCLYMLGVN
PremiumAI Analyst RatingsAI Models Upgrade AXTI on Turnaround Momentum, But Valuation Stays a Concern1d agoAXTI
PremiumRatingsCLYM116’s Differentiated APRIL ‘Sweeper’ Design Sets Up Phase I Data as Key Catalyst for IgA Nephropathy Outlook1d agoCLYM
CLYM116’s Differentiated APRIL ‘Sweeper’ Design Sets Up Phase I Data as Key Catalyst for IgA Nephropathy Outlook